BRD9 and acute myeloid leukemia: demonstrated that the BRD9 domain of SWI-SNF facilitates the leukemogenic ability of this chromatin-remodeling complex by facilitating the Myc transcription, the induction of cellular proliferation, and the inhibition of hematopoietic differentiation (Hohmann et al., 2016) that characterizes acute myeloid leukemia.